We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Alliance to Develop HLA-Typing Method

By HospiMedica staff writers
Posted on 24 Oct 2001
A collaborative agreement to evaluate and develop methods for typing human leukocyte antigens (HLA) using a simple-to-use sequencing technology has been announced by Pel-Freez Clinical Systems LLC (Stockholm, Sweden) and the Molecular Diagnostics Business Unit of Pyrosequencing AB (Milwaukee, WI, USA). More...
The announcement was made at the conference of the American Society for Histocompatibility and Immunogenetics in San Francisco (CA, USA).

HLA genes are highly variable, which has a significant impact on patients undergoing organ and bone marrow transplantation. To achieve the highest clinical success, the goal in transplantation is to accurately match the patterns of HLA variability of the donor and patient. DNA-based method for HLA typing have enabled diagnostic labs to better identify appropriate donors. Pel-Freez and Pyrosequencing plan to base their new typing method on proprietary technology developed by Pyrosequencing. This technology is broadly applicable for the analysis of single nucleotide polymorphisms (SNPs) and for the identification and quantification of short DNA sequences used in bacterial and viral typing.

"We believe the Pyrosequencing platform will be truly novel in the HLA field with its ability to simultaneously deliver speed, resolving power, and versatility,” said Frank Langley, president of Pel-Freez.




Related Links:
Pyrosequencing
Pel-Freez

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
New
Gastrointestinal Panel
Xpert® GI Panel
New
Next-Generation Sequencing Platform
AXELIOS 1 Platform
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Adobe Stock

Blood Biomarkers Help Assess Growth Risks During Steroid Treatment in Duchenne Muscular Dystrophy

Children with Duchenne muscular dystrophy (DMD) commonly receive long-term corticosteroids to slow disease progression, but these drugs can impair linear growth and weaken bone. Understanding how specific... Read more

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.